Complete report available @ http://www.rnrmarketresearch.com/gastrointestinal-therapeutics-in-major-developed-markets-to-2019-new-drug-approvals-and-promising-pipeline-to-counter-declines-from-patent-expiries-market-report.html . <br /> <br />Scope <br />• The report analyzes treatment usage patterns, market characterization, pipeline analysis and key licensing and co-development deals for the IBS, UC and CD indications in the major developed markets of the US, the UK, France, Germany, Italy, Spain, Japan and Canada. <br />• Disease overview and treatment usage patterns <br />• Market size and forecast for IBS, UC and CD in major developed markets from 2012 to 2019 <br />• Major marketed products for the indication types covered <br />• In-depth pipeline analysis for IBS, UC and CD <br />• Key drivers and restraints that have had and are expected to have a major impact upon the market <br />• Key licensing and co-development agreements in the gastrointestinal therapeutics market
